Processing your payment...
Please do not close your browser.

Biologic Therapeutic Drug Market- Global Growth, Trends and Forecast (2022 - 2029) By Products, By Application, By Source and By Regions

28 Jun, 2022 | 104 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next five years, the Biologic Therapeutic Drug Market will register a CAGR of 7.9 % in terms of revenue and the global market size will reach USD 601.8 Billion by 2029

Biologic Therapeutic Drug Market Overview

Genetically modified proteins made from human genetic material are called biological therapeutic medicines. They may include complicated mixtures of various ingredients, such as carbohydrates, proteins, and nucleic acids, or they may be living things like cells and tissues. Additionally, biological medications are taken from natural sources including humans, animals, and microbes. These sources are then used to create therapeutic products like recombinant therapeutic proteins, vaccinations, and blood components.

Increases in the incidence of chronic diseases including cancer, diabetes, and coronary artery diseases as well as an increase in the elderly population are the main drivers of the expansion of the market for biological therapeutic pharmaceuticals. Additionally, a significant number of clinical studies and creative R&D methods to create improved pharmaceuticals fuel market expansion. However, manufacturing challenges brought on by medicinal compounds' complexity restrain market expansion. Increased R&D efforts in the pharmaceutical sector and an increase in therapeutic applications are expected to open up new market prospects.

What is our Biologic Therapeutic Drug Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 7.9 % during the review period (2022 to 2029).

 

By Product

  • Vaccines
  • Blood and Blood Products
  • Allergenic Extracts
  • Human Cells and Tissues
  • Gene Therapies
  • Proteins
  • Cellular Therapies
  • Xenotransplantation Products

 

By Application

 

 

 

 

  • Rheumatoid Arthritis
  • Anemia
  • Cancer
  • Diabetes
  • Others

By Source

  • Humans
  • Avian Cell Culture
  • Yeast
  • Bacteria
  • Insects Cell Culture
  • Transgenics

 

 

 

By Companies

  • Pfizer Inc.
  • AstraZeneca
  • Novartis Global
  • Merck & Co. Inc.
  • Smith Medical
  • GlaxoSmithKline Plc.
  • Concord Biotech
  • Aurobindo Pharma Ltd.
  • H. Lundbeck A/S
  • Retractable Technologies, Inc.

 

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Historical Year

 

2017 to 2021

Forecast Year

2022 to 2029

Number of Pages

104

 

Customization Available

 

Yes, the report can be customized as per your needs

Who are the Major Players in Biologic Therapeutic Drug Market?

Market Growth Reports lists all the Biologic Therapeutic Drug Market companies that are presently striving to reduce the impact of the Covid-19 pandemic on the Market- Pfizer Inc., AstraZeneca, Novartis Global, Merck & Co. Inc., Smith Medical, GlaxoSmithKline Plc., Concord Biotech, Aurobindo Pharma Ltd., H. Lundbeck A/S, Retractable Technologies, Inc., Others

Industry News:

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19

KENILWORTH, Merck is known as MSD outside the United States and Canada, today announced it has agreed with the United States Government to support the development, manufacture, and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Merck acquired MK-7110 through the acquisition of OncoImmune, a privately held, clinical-stage biopharmaceutical company.

 

What are the major Product, Applications, and sources for Biologic Therapeutic Drug Market?

By Product, it is segmented into

  • Vaccines
  • Blood and Blood Products
  • Allergenic Extracts
  • Human Cells and Tissues
  • Gene Therapies
  • Proteins
  • Cellular Therapies
  • Xenotransplantation Products

By Application it is segmented into

  • Rheumatoid Arthritis
  • Anemia
  • Cancer
  • Diabetes
  • Others

By Source, it is segmented into

  • Humans
  • Avian Cell Culture
  • Yeast
  • Bacteria
  • Insects Cell Culture
  • Transgenics

Biologic Therapeutic Drug Market Regional Analysis

The market for biological Therapeutic is divided into four regions: North America, Asia Pacific, Europe, and the rest of the world (RoW). Throughout the projected period, North America will be the most attractive market for biological Therapeutic.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET BY-PRODUCTS
    • GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET BY APPLICATION
    • GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET BY SOURCE
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING GERIATRIC POPULATION AND PREVALENCE OF CHRONIC DISEASE
    • RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST OF MATERIALS
    • OPPORTUNITIES
      • BIOLOGIC THERAPEUTIC DRUG GROWTH
    • APPLICATION OF BIOLOGIC THERAPEUTIC DRUG IMPACT ON COVID 19
  5. GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET, BY-PRODUCTS
    • INTRODUCTION
    • VACCINES
    • BLOOD AND BLOOD PRODUCTS
    • ALLERGENIC EXTRACTS
    • HUMAN CELLS AND TISSUES
    • GENE THERAPIES
    • PROTEINS
    • CELLULAR THERAPIES
    • XENOTRANSPLANTATION PRODUCTS
  6. GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET, BY APPLICATION
    • INTRODUCTION
    • ANTI-INFLAMMATORIES
    • BRONCHODILATORS
    • ECTOPARASITICIDES
    • ENDOPARASITICIDES
  7. GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET, BY SOURCE
    • INTRODUCTION
    • HUMANS
    • AVIAN CELL CULTURE
    • YEAST
    • BACTERIA
    • INSECTS CELL CULTURE
    • TRANSGENICS
  8. GLOBAL BIOLOGIC THERAPEUTIC DRUG MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST AND AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  9. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE PERCENT/RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  10. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
  1. PFIZER INC.
  2. ASTRAZENECA
  3. NOVARTIS GLOBAL
  4. MERCK & CO. INC.
  5. SMITH MEDICAL
  6. GLAXOSMITHKLINE PLC.
  7. CONCORD BIOTECH
  8. AUROBINDO PHARMA LTD.
  9. H. LUNDBECK A/S
  10. RETRACTABLE TECHNOLOGIES, INC

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla